与安慰剂相比，微生物组治疗性SER-109可减少艰难梭菌感染(CDI)的复发，无论是否存在包括慢性阻塞性疾病(COPD)和哮喘在内的合并症

{"title":"与安慰剂相比，微生物组治疗性SER-109可减少艰难梭菌感染(CDI)的复发，无论是否存在包括慢性阻塞性疾病(COPD)和哮喘在内的合并症","authors":"B. Mcgovern, T. Louie, S. Cohen, M. Sims, E. Wang, H. Wu, K. Brady, L. V. von Moltke","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2792","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":403586,"journal":{"name":"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES","volume":"5 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Investigational Microbiome Therapeutic SER-109 Reduces Recurrence of Clostridioides DifficileInfection (CDI) Compared to Placebo, Regardless of Presence or Absence of Comorbidities Including Chronic Obstructive Disease (COPD) and Asthma\",\"authors\":\"B. Mcgovern, T. Louie, S. Cohen, M. Sims, E. Wang, H. Wu, K. Brady, L. V. von Moltke\",\"doi\":\"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2792\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":403586,\"journal\":{\"name\":\"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES\",\"volume\":\"5 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2792\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B39. COPD MANAGEMENT: FROM PHARMACOLOGIC TREATMENT TO NOVEL THERAPIES","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2792","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}